A carregar...
Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device
BACKGROUND: Targeted delivery of nerve growth factor (NGF) has emerged as a potential therapy for Alzheimer’s disease (AD) due to its regenerative effects on basal forebrain cholinergic neurons. This hypothesis has been tested in patients with AD using encapsulated cell biodelivery of NGF (NGF-ECB)...
Na minha lista:
Publicado no: | Alzheimers Res Ther |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4936020/ https://ncbi.nlm.nih.gov/pubmed/27389402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-016-0195-9 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|